D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 46,853 177 World Ranking 14815 National Ranking 493

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His main research concerns Osteoprotegerin, Internal medicine, Osteoclast, Endocrinology and Bone resorption. His work deals with themes such as Tumor necrosis factor alpha, Molecular biology and Arthritis, which intersect with Osteoprotegerin. Colin R. Dunstan studies Internal medicine, namely Bone cell.

His Osteoclast study integrates concerns from other disciplines, such as RANK Ligand, RANKL, Pathology, Cell biology and Bone disease. His work on Bone remodeling and Osteoporosis as part of his general Endocrinology study is frequently connected to Arterial calcification, thereby bridging the divide between different branches of science. As a part of the same scientific family, Colin R. Dunstan mostly works in the field of Bone resorption, focusing on Resorption and, on occasion, Cytoskeleton.

His most cited work include:

  • Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation (4702 citations)
  • Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density (4398 citations)
  • OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis (2875 citations)

What are the main themes of his work throughout his whole career to date?

Colin R. Dunstan spends much of his time researching Internal medicine, Endocrinology, Osteoprotegerin, Bone resorption and Osteoclast. His Internal medicine study frequently involves adjacent topics like Genetically modified mouse. The study incorporates disciplines such as Receptor and Osteoblast in addition to Endocrinology.

Colin R. Dunstan is involved in the study of Osteoprotegerin that focuses on RANK Ligand in particular. Colin R. Dunstan has included themes like Bone remodeling and Resorption in his Bone resorption study. His Osteoclast research includes themes of Molecular biology and Pathology.

He most often published in these fields:

  • Internal medicine (51.81%)
  • Endocrinology (41.97%)
  • Osteoprotegerin (36.79%)

What were the highlights of his more recent work (between 2012-2021)?

  • Biomedical engineering (16.58%)
  • Bone regeneration (11.40%)
  • Cancer research (11.40%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Biomedical engineering, Bone regeneration, Cancer research, Scaffold and Cancer cell. His study in Cancer research is interdisciplinary in nature, drawing from both Pathology, Signal transduction, Metastasis, Triple-negative breast cancer and Prostate cancer. His research in Signal transduction intersects with topics in Endocrinology, Gene knockdown, Calcitriol receptor, Internal medicine and Breast cancer.

He combines subjects such as Osteoclast and Multiple myeloma with his study of Endocrinology. His studies in Multiple myeloma integrate themes in fields like Osteoprotegerin and Bone disease. Bone resorption is closely connected to Bone remodeling in his research, which is encompassed under the umbrella topic of Osteoblast.

Between 2012 and 2021, his most popular works were:

  • Priming Adipose Stem Cells with Tumor Necrosis Factor-Alpha Preconditioning Potentiates Their Exosome Efficacy for Bone Regeneration. (58 citations)
  • Activation and promotion of adipose stem cells by tumour necrosis factor‐alpha preconditioning for bone regeneration (47 citations)
  • The influence of bone surface availability in bone remodelling—A mathematical model including coupled geometrical and biomechanical regulations of bone cells (45 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Colin R. Dunstan mainly focuses on Bone regeneration, Cancer research, Biomedical engineering, Osteoblast and Bone cell. His research on Cancer research also deals with topics like

  • Cancer cell that connect with fields like RANKL,
  • Signal transduction which intersects with area such as Prostate cancer,
  • Pathology together with Cancer metastasis and Skeletal metastasis. RANKL is a primary field of his research addressed under Internal medicine.

The Osteoblast study combines topics in areas such as Noggin and Cell biology. His Bone cell course of study focuses on Bone remodeling and Osteoclast. His research in Osteoclast focuses on subjects like Mechanobiology, which are connected to Bone resorption.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

D.L Lacey;E Timms;H.-L Tan;M.J Kelley.
Cell (1998)

6556 Citations

Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

W.S Simonet;D.L Lacey;C.R Dunstan;M Kelley.
Cell (1997)

6488 Citations

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Young-Yun Kong;Hiroki Yoshida;Ildiko Sarosi;Hong-Lin Tan.
Nature (1999)

3983 Citations

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

N. Bucay;I. Sarosi;C. R. Dunstan;S. Morony.
Genes & Development (1998)

2725 Citations

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Hailing Hsu;David L. Lacey;Colin R. Dunstan;Irina Solovyev.
Proceedings of the National Academy of Sciences of the United States of America (1999)

2092 Citations

Increased bone formation in osteocalcin-deficient mice

Patricia Ducy;Christelle Desbois;Brendan Boyce;Gerald Pinero.
Nature (1996)

1946 Citations

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

L C Hofbauer;S Khosla;C R Dunstan;D L Lacey.
Journal of Bone and Mineral Research (2000)

1596 Citations

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

Mark A. Lomaga;Wen Chen Yeh;Ildiko Sarosi;Gordon S. Duncan.
Genes & Development (1999)

1502 Citations

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

Ji Li;Ildiko Sarosi;Xiao-Qiang Yan;Sean Morony.
Proceedings of the National Academy of Sciences of the United States of America (2000)

1312 Citations

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts

Teresa L. Burgess;Yi-xin Qian;Stephen Kaufman;Brian D. Ring.
Journal of Cell Biology (1999)

982 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Colin R. Dunstan

Josef M. Penninger

Josef M. Penninger

University of British Columbia

Publications: 103

Georg Schett

Georg Schett

University of Erlangen-Nuremberg

Publications: 97

Nobuyuki Udagawa

Nobuyuki Udagawa

Matsumoto Dental University

Publications: 97

Lorenz C. Hofbauer

Lorenz C. Hofbauer

TU Dresden

Publications: 95

Dominique Heymann

Dominique Heymann

University of Nantes

Publications: 91

Gerard Karsenty

Gerard Karsenty

Columbia University

Publications: 90

Yongwon Choi

Yongwon Choi

University of Pennsylvania

Publications: 83

Hiroshi Takayanagi

Hiroshi Takayanagi

University of Tokyo

Publications: 81

Naoyuki Takahashi

Naoyuki Takahashi

Matsumoto Dental University

Publications: 81

Jiake Xu

Jiake Xu

University of Western Australia

Publications: 75

G. David Roodman

G. David Roodman

Indiana University

Publications: 66

Markus J. Seibel

Markus J. Seibel

University of Sydney

Publications: 63

T. John Martin

T. John Martin

St Vincents Institute of Medical Research

Publications: 55

Brendan F. Boyce

Brendan F. Boyce

University of Rochester Medical Center

Publications: 55

Sundeep Khosla

Sundeep Khosla

Mayo Clinic

Publications: 54

Edward M. Schwarz

Edward M. Schwarz

University of Rochester Medical Center

Publications: 54

Trending Scientists

Mark A. Stadtherr

Mark A. Stadtherr

The University of Texas at Austin

Kenneth R. Baker

Kenneth R. Baker

Dartmouth College

José M. Pingarrón

José M. Pingarrón

Complutense University of Madrid

Zuzanna S. Siwy

Zuzanna S. Siwy

University of California, Irvine

Anke Hinney

Anke Hinney

University of Duisburg-Essen

Jeffrey Maynard

Jeffrey Maynard

Wilmington University

Juan Miguel Redondo

Juan Miguel Redondo

Spanish National Centre for Cardiovascular Research

Charles H. Streuli

Charles H. Streuli

University of Manchester

Bernhard Kuster

Bernhard Kuster

Technical University of Munich

Alexander F. Markham

Alexander F. Markham

St James's University Hospital

Camille Dumat

Camille Dumat

École Nationale Supérieure Agronomique de Toulouse

Ralf Bennartz

Ralf Bennartz

Vanderbilt University

Djoher Nora Abrous

Djoher Nora Abrous

University of Bordeaux

Tatsuya Mima

Tatsuya Mima

Ritsumeikan University

Ladd Wheeler

Ladd Wheeler

Macquarie University

Paul W. Jones

Paul W. Jones

St George's, University of London

Something went wrong. Please try again later.